Goldman Sachs Group Inc G1 Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.2 - $4.98 $522,143 - $1.18 Million	-237,338 Reduced 52.98%	210,623 $480,000
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $916,647 - $2.11 Million	436,499 Added 3808.23%	447,961 $1.94 Million
Q4 2023 Feb 13, 2024	SELL	$1.12 - $3.73 $5,408 - $18,012	-4,829 Reduced 29.64%	11,462 $34,000
Q3 2023 May 14, 2024	BUY	$1.22 - $2.67 $5,891 - $12,893	4,829 Added 42.13%	16,291 $23,000
Q3 2023 Nov 14, 2023	SELL	$1.22 - $2.67 $97,386 - $213,132	-79,825 Reduced 83.05%	16,291 $23,000
Q2 2023 May 14, 2024	BUY	$2.46 - $3.14 $85,671 - $109,353	34,826 Added 56.82%	96,116 $239,000
Q2 2023 Aug 14, 2023	BUY	$2.46 - $3.14 $85,671 - $109,353	34,826 Added 56.82%	96,116 $239,000
Q1 2023 May 14, 2024	SELL	$2.57 - $8.16 $530,787 - $1.69 Million	-206,532 Reduced 77.12%	61,290 $164,000
Q1 2023 May 11, 2023	SELL	$2.57 - $8.16 $530,787 - $1.69 Million	-206,532 Reduced 77.12%	61,290 $164,000
Q4 2022 May 14, 2024	SELL	$5.19 - $13.5 $332,201 - $864,108	-64,008 Reduced 19.29%	267,822 $1.45 Million
Q4 2022 Feb 13, 2023	SELL	$5.19 - $13.5 $332,201 - $864,108	-64,008 Reduced 19.29%	267,822 $1.45 Million
Q3 2022 May 14, 2024	SELL	$5.17 - $16.99 $42,414 - $139,385	-8,204 Reduced 2.41%	331,830 $4.14 Million
Q3 2022 Nov 10, 2022	SELL	$5.17 - $16.99 $42,414 - $139,385	-8,204 Reduced 2.41%	331,830 $4.14 Million
Q2 2022 May 14, 2024	BUY	$4.04 - $8.51 $1.33 Million - $2.8 Million	328,572 Added 2866.62%	340,034 $1.68 Million
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $424,616 - $894,426	-105,103 Reduced 23.61%	340,034 $1.68 Million
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $465,006 - $674,258	61,185 Added 15.94%	445,137 $3.38 Million
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $3.09 Million - $4.91 Million	-303,752 Reduced 44.17%	383,952 $3.92 Million
Q3 2021 Nov 10, 2021	BUY	$13.16 - $22.47 $9.05 Million - $15.5 Million	687,704 New	687,704 $9.23 Million

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account